Altre lingue Neuren Pharmaceuticals Limited

Azioni

NEU

NZNEUE0001S8

Tempo differito Australian S.E. Altri mercati azionari 02:38:43 02/05/2024			Variaz. 5gg	Var. 1 gen.
19,02 ^AUD	-0,18%		-1,42%	-23,81%

24/04	Neuren Pharmaceuticals registra 243 milioni di dollari australiani in contanti e investimenti a breve termine	MT
29/02	Neuren Pharmaceuticals Limited fornisce una guida alle vendite per il primo trimestre e l'intero anno 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments	24/04
Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada	23/04
Weekly Top Ten News Stories - 15 March 2024	15/03
Neuren Pharmaceuticals Limited Provides Sales Guidance for the First Quarter and Full Year 2024	29/02
Neuren Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Culper Research discloses short position in Acadia Pharma	15/02
Neuren Pharmaceuticals Completes Recruitment for Phase Two Neurological Trial; Shares Fall 4%	20/12
LATE BRIEFING - Unternehmen und Märkte	18/12
MIDDAY BRIEFING - Unternehmen und Märkte	18/12
MÄRKTE ASIEN/Gewinnmitnahmen geben Richtung vor	18/12
MÄRKTE ASIEN/Zurückhaltung vor Fed-Entscheid - Tankan-Bericht stützt Tokio	13/12
Neuren Pharmaceuticals Concludes Enrollment for Phase 2 Trial in Pitt Hopkins Syndrome	05/12
Argenica Therapeutics Appoints Nonexecutive Chair	30/11
Neuren Pharmaceuticals Posts Higher Q3 Net Sales in US for Rett Syndrome Treatment	03/11
Fragile X Syndrome Pipeline, Clinical Trials Studies, Agreements & Collaborations, and Latest News 2023 (Updated)	10/10/23
Fragile X Syndrome Pipeline, Clinical Trials and NDA Approvals 2023 (Updated)	18/09/23
Neuren Pharmaceuticals Limited(ASX:NEU) added to S&P/ASX 200 Index	18/09/23
Neuren Pharmaceuticals Limited Reiterates Net Sales Guidance for the Third Quarter of 2023	28/08/23
Neuren Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Sector Update: Health Care Stocks Gain Pre-Bell Friday	14/07/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Neuren Pharmaceuticals Limited

Azioni

NEU

NZNEUE0001S8

Altre lingue

Filtri